Tuesday, September 25, 2018
 
 
Company News: Page (1) of 1 - 08/20/18 Email this story to a friend. email article Print this page (Article printing at MyDmn.com).print page facebook
WuXi Biologics Reports Robust 2018 Interim Results
 
(August 20, 2018)
This article is no longer available,but here are some related topics.


Page: 1


Related Keywords:USA,Business,Science,Financial,Medical,Cancer,Business,Science,
Related Sites: DMN Newswire ,   HTN - Health Technology Net
Related Newsletter: Tutorial Finder ,   Review Seeker ,   IBN - IT Weekly Newsletter ,   DMN Newswire Newsletter
 
 
 
 
 
 
 
Seniors

Drugs
  • ChenMed to Invest More Than $200 Million to Bring Affordable Concierge-Style Health Care to Philadelphia Seniors
  • $724 Million Viral Clearance Market by Application, End User, Method, Viral Inactivation - Global Forecasts to 2023
  • Global Viral Clearance Market 2018-2023 - Increasing Pharmaceutical Outsourcing & Emerging Markets Offer Opportunities
  • Global Automated Biochemistry Analyzers Market 2018-2022 - Increasing Use of Biochemical Tests for Pregnancy-Related Issues
  • The viral clearance market is projected to grow at a CAGR of 21.7%

    Cancer
  • Rose Medical Center's Cancer Program Re-Accredited by the Commission on Cancer
  • Citius Announces The Issuance Of The Patent On The Advanced Stability Of Mino-Lok® By USPTO
  • GlycoMark®, Inc. Announces Partnership with Premier Medical Laboratory Services to Expand Diabetes Test Menu
  • SOPHiA GENETICS Sets up Headquarters in Boston to Meet Growing Demand in the U.S.
  • SOPHiA GENETICS Sets up Headquarters in Boston to Meet Growing Demand in the U.S.
  •  
     
     
     
     
     





    Our Privacy Policy --- About The Health Technology - Contact Us - Advertise With Us - Privacy Guidelines